Yahoo Search Busca da Web

Resultado da Busca

  1. 29 de mai. de 2020 · Microsoft’s first Chief Scientific Officer, Technical Fellow and world-renowned AI researcher, Dr. Eric Horvitz, gives us an insider’s look into how the expe...

    • 65 min
    • 3,5K
    • Microsoft
  2. 20 de fev. de 2024 · The Chief Scientific Officer (CSO) stands at the helm of an organization’s scientific, research, and technological operations, steering the development and innovation of new products, services, or methodologies. This role encompasses the strategic integration of scientific knowledge with business objectives, ensuring that the company’s ...

  3. The Chief Scientific Adviser to the UK's Ministry of Defence is responsible for providing strategic management of science and technology issues in the MOD, most directly through the MOD research budget of well over £1 billion, and sits as a full member of the Defence Management Board and the Defence Council, the two most senior management boards within the MOD.

  4. 20 de fev. de 2023 · Last modified on Mon 20 Feb 2023 14.31 EST. Dame Angela McLean has been appointed as the UK’s chief scientific adviser – the first woman to hold the post. McLean will take over the role of ...

  5. A chief experimental officer (CEO) is the head of an experimental organization, especially in the military or civil service. Chief Experimental Officer has been the topmost class in the Experimental Officer Class of the British Civil Service. See also. Chief executive officer (CEO) Chief innovation officer (CINO) Chief scientific officer (CSO)

  6. Chief Scientific Adviser may refer to: Chief Science Advisor (Canada) Chief Scientific Adviser to the Ministry of Defence, United Kingdom. Government Chief Scientific Adviser (United Kingdom) Office of the Chief Scientist (Australia) Government Chief Scientific Adviser (Ireland) Principal Scientific Adviser to the Government of India.

  7. Tony was appointed Chief Scientific Officer designate on 19 January 2022 and became Chief Scientific Officer, with full accountability for GSK R&D, with effect from 1 August 2022. Tony is a highly respected scientist and one of the world’s pre-eminent medicinal chemists, with more than 30 years of experience working across diverse disciplines of R&D to deliver innovative medicines.